More Flu Season Stock Winners (HITK, PTX, PRGO)
ThinkstockThe 2012 to 2013 flu season has reached what is officially at pandemic levels. The government report last week showed that more than 7% of the deaths in the prior week were tied to…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 311Can Dendreon’s Stock Really Double Again?
ThinkstockDendreon Corp. (NASDAQ: DNDN) is seeing shares surge higher on Friday on an analyst upgrade. The move higher is part because Dendreon has a long history of boom and bust with large share price…
ArQule Fails in Colorectal Cancer Trials
ThinkstockArQule Inc. (NASDAQ: ARQL) is about to lose some serious hope for investors. It and Daiichi Sankyo announced that the top-line results of phase 2 trial with tivantinib in colorectal cancer did not meet the primary endpoint of…
The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you look at…
Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit
ThinkstockAmgen Inc. (NASDAQ: AMGN) is holding up better than some investors might have expected after the biotech giant warned about earnings. The lowering of earnings estimates was by a mere $0.10 for 2012 and…
Celgene Guidance Brings All-Time Highs… What Lies Ahead
ThinkstockCelgene Corporation (NASDAQ: CELG) has issued some long-term guidance which appears to be at the high-end of its previous range. The move is taking shares higher, but not just higher with a small gain…
Biotech and BioHealth Top Stocks on the Move (ACHN, CBMX, DNDN, EXAS, ILMN, PPHM, VVUS)
ThinkstockThere are big movers in the market just about every day, and these movers often come from biotech and other emerging health care winners and losers. The daily direction of the broad market does…
12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)
It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over the next year. Our own DJIA peak price target is up 11.3% at 14,590,…
Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec
ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) is living up to why we just said it is now an overvalued biotech stock for 2013. Biogen Idec and the other biotech giants had risen perhaps too much in 2012, and…
Alexza FDA Approval: Coal in the Christmas Stocking?
ThinkstockAlexza Pharmaceuticals, Inc. (NASDAQ: ALXA) is seeing its shareholders get nothing but coal for Christmas this year. The stock is the largest loser on the NASDAQ today with a drop of nearly 14% to…
How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)
The largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013. If Wall St. analysts are correct, biotech and biohealth investors are going to have…
Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for the coming…
Is There Finally a Winner in the Crowded Obesity Drug Market?
ThinkstockAccording to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2 diabetes and even certain types…
Analyst: Biogen Idec Gains Are Done
ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) has had a great 2012. Actually, it has had a hell of a year with a gain of almost 40% year to date. When you compare this to the iShares Nasdaq…
J.P. Morgan Sees More Upside in Hospital Stocks (CYH, HCA, LPNT, THC, UHS, HMA, VHS)
ThinkstockJ.P. Morgan Chase & Co. (NYSE: JPM) has issued a research call that calls for some very large upside in the hospital sector. We would note that most of these stocks have already enjoyed…